TEAS Rev, App and/or COA of Atty/Dom.Rep

THERAFLU

GSK CONSUMER HEALTHCARE SARL

Revocation of Attorney/Domestic Representative and/or Appointment of Attorney/Domestic Representative

PTO Form 2196 (Rev 9/2005)
OMB No. 0651-0056 (Exp 9/30/2017)

Revocation of Attorney/Domestic Representative and/or Appointment of Attorney/Domestic Representative


The table below presents the data as entered.

Input Field Entered
SERIAL NUMBER 73637147
REGISTRATION NUMBER 1452879
ATTORNEY DOCKET NUMBER TMR 5120589/MAS/095
MARK SECTION
MARK THERAFLU
ATTORNEY SECTION
ORIGINAL ADDRESS Mary F. Leheny
200 Kimball Drive
Parsippany New Jersey (NJ) 07054
US
973-503-8303
973-503-8450
mary.leheny@novartis.com
NEW ATTORNEY ADDRESS
STATEMENT TEXT By submission of this request, the undersigned REVOKES the power of attorney currently of record, as listed above, and hereby APPOINTS the following new attorney:
NAME Charles M. Atkinson
FIRM NAME GlaxoSmithKline
INTERNAL ADDRESS LGTM - NY0300
STREET 5 Crescent Drive
CITY Philadelphia
STATE Pennsylvania
COUNTRY United States
POSTAL/ZIP CODE 19112
PHONE 484-431-5142
FAX 215-751-7051
EMAIL trademarks@gsk.com
ATTORNEY AUTHORIZED TO COMMUNICATE VIA E-MAIL YES
ATTORNEY DOCKET NUMBER TMR 5120589/MAS/095
NEW OTHER APPOINTED ATTORNEYS Terence A. Dixon, Christopher Hanes, Diane Fry Maginnis, Angela L. Wilson
NEW DOMESTIC REPRESENTATIVE ADDRESS
STATEMENT TEXT By submission of this request, the undersigned hereby APPOINTS the following new domestic representative upon whom notices or process affecting the mark may be served:
NAME Charles M. Atkinson
FIRM NAME GlaxoSmithKline
INTERNAL ADDRESS LGTM - NY0300
STREET 5 Crescent Drive
CITY Philadelphia
STATE Pennsylvania
COUNTRY United States
POSTAL/ZIP CODE 19112
PHONE 484-431-5142
FAX 215-751-7051
EMAIL trademarks@gsk.com
REPRESENTATIVE AUTHORIZED TO COMMUNICATE VIA E-MAIL YES
OTHER APPOINTED ATTORNEY Terence A. Dixon, Christopher Hanes, Diane Fry Maginnis, Angela L. Wilson
NEW CORRESPONDENCE ADDRESS
NAME Charles M. Atkinson
FIRM NAME GlaxoSmithKline
DOCKET/REFERENCE NUMBER TMR 5113982/MAS/095
INTERNAL ADDRESS LGTM - NY0300
STREET 5 Crescent Drive
CITY Philadelphia
STATE Pennsylvania
COUNTRY United States
POSTAL/ZIP CODE 19112
PHONE 484-431-5142
FAX 215-751-7051
EMAIL trademarks@gsk.com
AUTHORIZED TO COMMUNICATE VIA E-MAIL YES
OTHER APPOINTED ATTORNEY Terence A. Dixon, Christopher Hanes, Diane Fry Maginnis, Angela L. Wilson
SIGNATURE SECTION
SIGNATURE /Charles M. Atkinson/
SIGNATORY NAME Charles M. Atkinson
SIGNATORY DATE 12/02/2015
SIGNATORY POSITION VP & Trade Mark Counsel, Attorney in fact for Novartis Consumer Health S.A. (New York bar member)
SIGNATORY PHONE NUMBER 484-431-5142
FILING INFORMATION SECTION
SUBMIT DATE Wed Dec 02 08:56:33 EST 2015
TEAS STAMP USPTO/RAA-XXX.XX.XX.X-201
51202085633398625-7167189
5-540274678317629c28876e5
b32e729d229a2f4397259b709
17fe6d96a6adb5-N/A-N/A-20
151201143318292647



PTO Form 2196 (Rev 9/2005)
OMB No. 0651-0056 (Exp 9/30/2017)


Revocation of Attorney/Domestic Representative and/or Appointment of Attorney/Domestic Representative


To the Commissioner for Trademarks:
MARK: THERAFLU
SERIAL NUMBER: 73637147
REGISTRATION NUMBER: 1452879
ATTORNEY DOCKET NUMBER TMR 5120589/MAS/095

The original attorney
Mary F. Leheny
200 Kimball Drive
Parsippany New Jersey 07054
US
973-503-8303
973-503-8450
mary.leheny@novartis.com

Original Correspondence Address :
Mary F. Leheny
Novartis
200 Kimball Drive
Parsippany New Jersey 07054
US
973-503-8303
973-503-8450
mary.leheny@novartis.com


By submission of this request, the undersigned REVOKES the power of attorney currently of record, as listed above, and hereby APPOINTS the following new attorney: In addition, any additional previously-appointed attorneys that are currently listed in the application are replaced with the new "Other Appointed Attorneys" listed below.

Newly Appointed Attorney:
Charles M. Atkinson
GlaxoSmithKline
LGTM - NY0300
5 Crescent Drive
Philadelphia, Pennsylvania 19112
United States
484-431-5142
215-751-7051
trademarks@gsk.com
TMR 5120589/MAS/095

Other Appointed Attorneys:

Terence A. Dixon, Christopher Hanes, Diane Fry Maginnis, Angela L. Wilson


By submission of this request, the undersigned hereby APPOINTS the following new domestic representative upon whom notices or process affecting the mark may be served:

Newly Appointed Representative:

Charles M. Atkinson
GlaxoSmithKline
LGTM - NY0300
5 Crescent Drive
Philadelphia, Pennsylvania 19112
United States
484-431-5142
215-751-7051
trademarks@gsk.com

The following is to be used as the correspondence address:
Charles M. Atkinson
GlaxoSmithKline
LGTM - NY0300
5 Crescent Drive
Philadelphia, Pennsylvania 19112
United States

484-431-5142
215-751-7051
trademarks@gsk.com The attorney docket/reference number is TMR 5113982/MAS/095.



Signature: /Charles M. Atkinson/      Date: 12/02/2015
Signatory's Name: Charles M. Atkinson
Signatory's Position: VP & Trade Mark Counsel, Attorney in fact for Novartis Consumer Health S.A. (New York bar member)
Signatory's Phone Number: 484-431-5142

Serial Number: 73637147
Internet Transmission Date: Wed Dec 02 08:56:33 EST 2015
TEAS Stamp: USPTO/RAA-XXX.XX.XX.X-201512020856333986
25-71671895-540274678317629c28876e5b32e7
29d229a2f4397259b70917fe6d96a6adb5-N/A-N
/A-20151201143318292647



uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed